The Pathway-based Brief Assessment of Cognition is quick and easy to administer while preserving the human interaction of traditional neurocognitive testing that is necessary for impaired populations. The electronic BAC Assessment provides investigators with meaningful results while reducing rater and patient burden. The Pathway-based Brief Assessment of Cognition in Schizophrenia is a proprietary measure designed by VeraSci experts.